Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 18.36 -0.47 (-2.5%) Market Cap: 497.32 Mil Enterprise Value: 302.30 Mil PE Ratio: 0 PB Ratio: 1.90 GF Score: 76/100

Q3 2024 Arcturus Therapeutics Holdings Inc Earnings Call Transcript

Nov 07, 2024 / 09:30PM GMT
Release Date Price: $18.74 (+2.24%)
Operator

(Operator Instructions)

Good day, everyone and welcome to today's Arcturus Therapeutics third-quarter 2024 earnings conference call. (Operator Instructions) Please note this call may be recorded, and I will be standing by if you should need any assistance.

It is now my pleasure to turn the conference over to Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing. Please go ahead.

Neda Safarzadeh
Arcturus Therapeutics Holdings Inc - Vice President - Head of Investor Relations, Public Relations and Marketing

Thank you, operator. Good afternoon and welcome to Arcturus Therapeutics quarterly financial update and pipeline progress call. Today's call will be led by Joe Payne, our President and CEO; and Andy Sassine, our CFO; Dr Pad Chivukula, our CSO and COO will join them for the Q&A station.

Before we begin, I would like to remind everyone that the statements made during this call regarding matters that are not historical facts or forward-looking statements within the safe harbor provisions of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot